Induction of oral tolerance to treat autoimmune and allergic diseases by using transgenic plants

Molecular Farming in Plants: Recent Advances and Future Prospects

Volumn 9789400722170, Issue , 2012, Pages 21-35

  Ma, Shengwu ^a,b   Jevnikar, Anthony M ^a  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84871692048     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-2217-0_2     Document Type: Chapter

References (54)

1. Arabi YM, Tamim HM, Rishu AH (2009) Hypoglycemia with intensive insulin therapy in critically ill patients: predisposing factors and association with mortality. Crit Care Med 37(9): 2536-2544
2. Arakawa T, Yu J, Chong DK, Hough J, Engen PC, Langridge WH (1998) A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nat Biotechnol 16(10):934-938
3. Asero R, Mistrello G, Roncarolo D, Amato S (2002) Allergenic similarity of 2S albumins. Allergy 57(1):62-63
4. Balding J, Livingstone WJ, Conroy J, Mynett-Johnson L, Weir DG, Mahmud N, Smith OP (2004) Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm 13(3):181-187
5. Beebe AM, Cua DJ, de Waal MR (2002) The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13(4-5):403-412
6. Bortesi L, Rossato M, Schuster F, Raven N, Stadlmann J, Avesani L, Falorni A, Bazzoni F, Bock R, Schillberg S, Pezzotti M (2009) Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco. BMC Biotechnol 9:22
7. Bouma G, Strober W (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3(7):521-533
8. Brandsma ME, Diao H, Wang X, Kohalmi SE, Jevnikar AM, Ma S (2010) Plant-derived recombinant human serum transferrin demonstrates multiple functions. Plant Biotechnol J 8(4):489-505
9. Bu DF, Erlander MG, Hitz BC, Tillakaratne NJ, Kaufman DL, Wagner-McPherson CB, Evans GA, Tobin AJ (1992) Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 89(6):2115-2119
10. Chebolu S, Daniell H (2009) Chloroplast-derived vaccine antigens and biopharmaceuticals: expression, folding, assembly and functionality. Curr Top Microbiol Immunol 332:33-54
11. Clark AT, Islam S, King Y, Deighton J, Anagnos-tou K, Ewan PW (2009) Successful oral tolerance induction in severe peanut allergy. Allergy 64(8):1218-1220
12. Douthwaite J, Jermutus L (2006) Exploiting directed evolution for the discovery of biologicals. Curr Opin Drug Discov Dev 9(2):269-275
13. Dove A (2002) Uncorking the biomanufacturing bottleneck. Nat Biotechnol 20(8):777-779
14. Eisenbarth GS (2004) Type 1 diabetes: molecular, cellular and clinical immunology. Adv Exp Med Biol 552:306-310
15. Elliott JF, Qin HY, Bhatti S, Smith DK, Singh RK, Dillon T, Lauzon J, Singh B (1994) Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes 43(12):1494-1499
16. Faria AM, Weiner HL (2006) Oral tolerance: therapeutic implications for autoimmune diseases. Clin Dev Immunol 13(2-4):143-157
17. Franklin SE, Mayfield SP (2004) Prospects for molecular farming in the green alga Chlamydomonas. Curr Opin Plant Biol 7(2):159-165
18. Frossard CP, Steidler L, Eigenmann PA (2007) Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization. J Allergy Clin Immunol 119(4):952-959
19. Hashizume F, Hino S, Kakehashi M, Okajima T, Nadano D, Aoki N, Matsuda T (2008) Development and evaluation of transgenic rice seeds accumulating a type II-collagen tolerogenic peptide. Transgenic Res 17(6):1117-1129
20. Huibregtse IL, Snoeck V, de Creus A, Braat H, De Jong EC, Van Deventer SJ, Rottiers P (2007) Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin. Gastroenterology 133(2):517-528
21. Ichim TE, Zheng X, Suzuki M, Kubo N, Zhang X, Min LR, Beduhn ME, Riordan NH, Inman RD, Min WP (2008) Antigen-specific therapy of rheumatoid arthritis. Expert Opin Biol Ther 8(2):191-199
22. Jasinski JM, Eisenbarth GS (2005) Insulin as a primary autoantigen for type 1A diabetes. Clin Dev Immunol 12(3):181-186
23. Kalischuk LD, Buret AG (2010) A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease? Am J Physiol Gastrointest Liver Physiol 298(1):G1-9
24. Koffeman EC, Genovese M, Amox D, Keogh E, Santana E, Matteson EL, Kavanaugh A, Molitor JA, Schiff MH, Posever JO, Bathon JM, Kivitz AJ, Samodal R, Belardi F, Dennehey C, van den Broek T, van Wijk F, Zhang X, Zieseniss P, Le T, Prakken BA, Cutter GC, Albani S (2009) Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial. Arthritis Rheum 60(11):3207-3216
25. Kozuch PL, Hanauer SB (2008) Treatment of inflammatory bowel disease: a review of medical therapy. World J Gastroenterol 14(3):354-377
26. Larché M, Wraith DC (2005) Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 11(4 Suppl):S69-S76
27. Lee C, Ho H, Lee K, Jeng S, Chiang B (2011) Construction of a Der p2-transgenic plant for the alleviation of airway inflammation. Cell Mol Immunol 8(5):404-414
28. Ma S, Zhao DL, Yin ZQ, Mukherjee R, Singh B, Qin HY, Stiller CR, Jevnikar AM (1997) Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat Med 3(7):793-796
29. Ma S, Huang Y, Yin Z, Menassa R, Brandle JE, Jevnikar AM (2004) Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4. Proc Natl Acad Sci USA 101(15):5680-5685
30. Massa M, Passalia M, Manzoni SM, Campanelli R, Ciardelli L, Yung GP, Kamphuis S, Pistorio A, Meli V, Sette A, Prakken B, Martini A, Albani S (2007) Differential recognition of heat-shock protein DNAJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis. Arthritis Rheum 56(5):1648-1657
31. Menassa R, Du C, Yin ZQ, Ma S, Poussier P, Brandle J, Jevnikar AM (2007) Therapeutic effectiveness of orally administered transgenic low-alkaloid tobacco expressing human interleukin-10 in a mouse model of colitis. Plant Biotechnol J 5(1):50-59
32. Moghadam-Kia S, Werth VP (2010) Prevention and treatment of systemic glucocorticoid side effects. Int J Dermatol 49(3):239-248
33. Morandini F, Avesani L, Bortesi L, Van Droogenbroeck B, De Wilde K, Arcalis E, Bazzoni F, Santi L, Brozzetti A, Falorni A, Stoger E, Depicker A, Pezzotti M (2011) Non-food/feed seeds as biofactories for the high-yield production of recombinant pharmaceuticals. Plant Biotechnol J. doi: 10.1111/j.1467-7652.2011
34. Niederberger V, Valenta R (2004) Recombinant allergens for immunotherapy. Where do we stand? Curr Opin Allergy Clin Immunol 4(6):549-554
35. Park KS, Park MJ, Cho ML, Kwok SK, Ju JH, Ko HJ, Park SH, Kim HY (2009) Type II collagen oral tolerance: mechanism and role in ollagen-induced arthritis and rheumatoid arthritis. Mod Rheumatol 19(6):581-589
36. Paul M, Ma JK (2011) Plant-made pharmaceuticals: leading products and production platforms. Biotechnol Appl Biochem 58(1):58-67
37. Penney CA, Thomas DR, Deen SS, Walmsley AM (2011) Plant-made vaccines in support of the Millennium Development Goals. Plant Cell Rep 30(5):789-798
38. Rasala BA, Mayfield SP (2011) The microalga Chlamydomonas reinhardtii as a platform for the production of human protein therapeutics. Bioeng Bugs 2(1):50-54
39. Rodríguez-Narciso C, Pérez-Tapia M, Rangel-Cano RM, Silva CL, Meckes-Fisher M, Salgado-Garciglia R, Estrada-Parra S, López-Gómez R, Estrada-García I (2011) Expression of Mycobacterium leprae HSP65 in tobacco and its effectiveness as an oral treatment in adjuvantinduced arthritis. Transgenic Res 20(2):221-229
40. Ruhlman T, Ahangari R, Devine A, Samsam M, Daniell H (2007) Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts-oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol J 5(4):495-510
41. Skyler JS (2008) Update on worldwide efforts to prevent type 1 diabetes. Ann N Y Acad Sci 1150: 190-196
42. Smart V, Foster PS, Rothenberg ME, Higgins TJ, Hogan SP (2003) A plant-based allergy vaccine suppresses experimental asthma via an IFN-gamma and CD4 + CD45RBlow T cell-dependent mechanism. J Immunol 171(4):2116-2126
43. Smith AM, Benjamin DC, Hozic N, Derewenda U, Smith WA, Thomas WR, Gafvelin G, van Hage-Hamsten M, Chapman MD (2001) The molecular basis of antigenic cross-reactivity between the group 2 mite allergens. J Allergy Clin Immunol 107(6):977-984
44. Sun JB, Czerkinsky C, Holmgren J (2010) Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand J Immunol 71(1):1-11
45. Suzuki K, Kaminuma O, Yang L, Takai T, Mori A, Umezu-Goto M, Ohtomo T, Ohmachi Y, Noda Y, Hirose S, Okumura K, Ogawa H, Takada K, Hirasawa M, Hiroi T, Takaiwa F (2011) Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression. Plant Biotechnol J. doi: 10.1111/j.1467-7652.2011
46. Takagi H, Hiroi T, Yang L, Tada Y, Yuki Y, Takamura K, Ishimitsu R, Kawauchi H, Kiyono H, Takaiwa F (2005) A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Proc Natl Acad Sci USA 102(48): 17525-17530
47. Takagi H et al (2008) Efficient induction of oral tolerance by fusing cholera toxin B subunit with allergen-specific T-cell epitopes accumulated in rice seed. Vaccine 26:6027-6030
48. Takaiwa F (2007) A rice-based edible vaccine expressing multiple T-cell epitopes to induce oral tolerance and inhibit allergy. Immunol Allergy Clin North Am 27(1):129-139
49. Tremblay R, Wang D, Jevnikar AM, Ma S (2010) Tobacco, a highly efficient green bioreactor for production of therapeutic proteins. Biotechnol Adv 28:214-221
50. Tzfira T, Citovsky V (2006) Agrobacterium-mediated genetic transformation of plants: biology and biotechnology. Curr Opin Biotechnol 17:147-154
51. Verma D, Moghimi B, LoDuca PA, Singh HD, Hoffman BE, Herzog RW, Daniell H (2010) Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice. Proc Natl Acad Sci USA 107(15):7101-7106
52. Wang X, Brandsma M, Tremblay R, Maxwell D, Jevnikar AM, Huner N, Ma S (2008) A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65). BMC Biotechnol 8:87
53. Weiner HL, da Cunha AP, Quintana F, Wu H (2011) Oral tolerance. Immunol Rev 241(1): 241-259
54. Zhang L, Eisenbarth GS (2011) Prediction and prevention of Type 1 diabetes mellitus. J Diabetes 3(1):48-57